This is a controlled document. If you are using a printed copy, check it against the guidelines site to ensure you are using the latest edition. Print copies must be destroyed after use.

This is a controlled document. If you are using a printed copy, check it against the guidelines site to ensure you are using the latest edition. Print copies must be destroyed after use.

| Version: | 2.0 |
|---|---|
| Guidelines Lead(s): | Dr James Gratwicke Consultant Neurologist |
| Contributor(s): | |
| Lead Director / Chief of Service: | Dr Chris Orchard, CoS for Medicine |
| Library check completed: | N/A |
| Ratified at: | Neurology Clinical Governance 16/09/2025 |
| Date Issued: | 07/10/2025 |
| Review Date: | 01/09/2028 |
| Pharmaceutical dosing advice and formulary compliance checked by: | N/A |
| Key words: | Seizure Epileptic, Known Epileptic, self-terminating seizure |
This guideline has been registered with the Trust. However, clinical guidelines are guidelines only. The interpretation and application of clinical guidelines will remain the responsibility of the individual clinician. If in doubt, contact a senior colleague or expert. Caution is advised when using guidelines after the review date.
This guideline is for use in Frimley Health NHS Foundation Trust hospitals only. Any use outside this location will not be supported by the Trust and will be at the risk of the individual using it.
Version History
| Version | Date | Guideline Lead(s) | Status | Comment |
|---|---|---|---|---|
| 1.0 | 30/08/2018 | Final | Uploaded to Guideline app. | |
| 2.0 | September 2025 | Dr James Gratwicke Consultant Neurologist | Final | Schedule review |
Related Documents
| Document Type | Document Name |
|---|---|
| Nice | Overview Epilepsies in children, young people and adults |